AptarGroup price target raised to $163 from $160 at Wells Fargo

Wells Fargo raised the firm’s price target on AptarGroup to $163 from $160 and keeps an Overweight rating on the shares. The firm remains constructive on AptarGroup’s Pharma outlook given its robust pipeline and new capacity rollout in 2024/2025. Further, improved execution in Beauty and incremental cost-out efforts in Closures supports a strong go forward investment case, Wells adds.